يعرض 141 - 160 نتائج من 35,023 نتيجة بحث عن '(( 59 mean decrease ) OR ((( 50 ((ms decrease) OR (a decrease)) ) OR ( a non decrease ))))', وقت الاستعلام: 0.71s تنقيح النتائج
  1. 141

    Colon tissue and organoid AJC protein expression is decreased with LD shifting in Per2::Luc mice. حسب Laura Tran (10924702)

    منشور في 2021
    "…<b>(D)</b> Immunofluorescent staining of cytoskeleton protein Krt-20 (green) in the colon tissue and organoids of shifted and non-shifted Per2::Luc mice. Both tissue and the organoids demonstrated a significant decrease in Krt-20 after shifting (p = 0.0086, 0.020). …"
  2. 142
  3. 143
  4. 144
  5. 145
  6. 146

    Elevated IDO activity in HD mouse brains is decreased by <i>ex-vivo</i> iron chelation. حسب David W. Donley (3111198)

    منشور في 2021
    "…<p>Mouse pups were supplemented with carbonyl iron from postnatal days 10–17 and then were sacrificed at 14 weeks of age. <b>A.</b> Striatal IDO activity is increased in N171-82Q HD mice and significantly decreased by <i>ex vivo</i> iron (III) chelation (50 μM deferoxamine). …"
  7. 147
  8. 148
  9. 149
  10. 150
  11. 151
  12. 152
  13. 153
  14. 154

    20E repressed ILP-mediated cell membrane translocation of HaP60 and HaP110, dephosphorylated HaP60 and HaP110, and decreased their interaction. حسب Yu-Qin Di (8752317)

    منشور في 2021
    "…Green, HaP60 or HaP110; red, cell membrane stained with WGA; blue, nuclei stained with DAPI; merge, overlapped green, blue, and red fluorescence. Bar, 50 μm. <b>C.</b> Co-IP assay showed that 20E decreased the HaP60–HaP110 interaction and induced dephosphorylation in cells. …"
  15. 155

    Data_Sheet_1_rdHSV-CA8 non-opioid analgesic gene therapy decreases somatosensory neuronal excitability by activating Kv7 voltage-gated potassium channels.docx حسب Munal B. Kandel (18526539)

    منشور في 2024
    "…These data demonstrate for the first time that vHCA8 produces Kv7 channel activation, which decreases neuronal excitability in nociceptors. This suppression of excitability may translate in vivo as non-opioid dependent behavioral- or clinical analgesia, if proven behaviorally and clinically.…"
  16. 156
  17. 157
  18. 158
  19. 159
  20. 160